ADVA
21.9.2021 09:02:50 CEST | Business Wire | Press release
ADVA (FSE: ADV) and SIA, Indra’s cybersecurity company, today announced that RedIRIS is deploying ADVA’s technology to create a robust, high-capacity research and education network (NREN). The new long-haul backbone infrastructure connects universities and research facilities across Spain, enabling educators and scientists to share huge data sets and harness bandwidth-intensive applications. Built on the ADVA FSP 3000 and monitored by the ADVA ALM fiber assurance solution, the network carries services at speeds up to 200Gbit/s. Featuring ADVA’s ROADM technology and QuadFlex™ line cards, the open solution has given RedIRIS an easy way to migrate from legacy technology to flexible, high-performance connectivity.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210921005058/en/
“Our new transport system empowers Spain’s scientists and academics to work together on national and international projects under optimum conditions. With flexible coherent wavelengths up to 200Gbit/s, it provides secure, highly reliable access to everything from video conferencing tools to high-performance remote computing facilities,” said Esther Robles, head of communications networks, RedIRIS. “ADVA’s open FSP 3000 technology enabled a smooth and painless transition from our existing transport infrastructure. With its modular design, it also provides massive scale, giving us the freedom to easily expand and evolve our network to meet future needs.”
Connecting more than 80 points of presence and over 500 institutions, RedIRIS’s new backbone network includes long-haul single-span submarine links to Spain’s Balearic Islands and the city of Melilla, as well as connections to the Canary Islands, the Canarian Institute of Astrophysics and its observatories. For flexibility and high spectral efficiency, the solution features ADVA’s flexgrid multi-degree ROADMs, enabling high-speed coherent and high-baud-rate transport. Through ADVA’s MicroMux™ technology, the new infrastructure also supports a seamless mix of 10Gbit/s and 100Gbit/s Ethernet client ports without any footprint increase. This optimizes space efficiency and ensures no stranded bandwidth. The network upgrade also involved the deployment of a solid and thorough migration plan by SIA, a leading Indra company in cybersecurity and ADVA’s Select partner.
“RedIRIS’s long-haul infrastructure is now one of Europe’s most advanced NRENs. It will enable researchers and teachers in Spain to leverage a new breed of data-intensive applications and collaborate in new ways using innovative video conferencing and augmented reality tools,” commented Hartmut Müller-Leitloff, SVP, sales, EMEA, ADVA. “Our open and scalable technology efficiently bridges the gap between the legacy needs and the future demand of RedIRIS’s users. Its unique client port flexibility supports a mix of 10Gbit/s and 100Gbit/s Ethernet services without the need for additional hardware. With our open optical layer, RedIRIS is also free to tackle rising demands in the future by expanding to higher baud rates and more complex modulation schemes.”
“For the design and deployment of a complex project like this, it has been key to walk hand in hand with our client RedIRIS, to perfectly understand its requirements and choose the right professionals with the knowledge and capacity to migrate to a new network that meets the organization’s present and future needs for a wide range of services. The project allows RedIRIS to carry encoded critical services that assure a greater level of cybersecurity with no latency,” stated Alejandro Díez, director, digital risk, SIA. “This deployment gives RedIRIS’s users in the research and scientific community an extremely powerful tool for high-quality collaboration and global connectivity. It also prepares Spain’s NREN for the key challenges of the future as it looks to connect more schools, universities, research centers, global libraries, smart cities and IoT. RedIRIS will operate as a critical infrastructure and will assure an immediate communication service with any other geographic point of the network, with robust processes and higher cybersecurity.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .
About Indra
Indra is one of the leading global technology and consulting companies and the technological partner for core business operations of its customers world-wide. It is a world-leader in providing proprietary solutions in specific segments in Transport and Defense markets, and a leading firm in Digital Transformation and Information Technologies in Spain and Latin America through its affiliate Minsait. Its business model is based on a comprehensive range of proprietary products, with a high-value focus and with a high innovation component. In the 2020 financial year, Indra achieved revenue of €3.043 billion, near 48,000 employees, a local presence in 46 countries and business operations in over 140 countries. www.indracompany.com
About SIA
SIA is the Indra company leading the cybersecurity sector in Spain and Portugal, both in terms of turnover and expert talent, with more than 1,200 specialists. Its value proposition is based on the specific responses it offers organizations to meet the challenges and threats posed by the four forces of digitalization: regulatory pressure, connected infrastructures, the transformation of IT architectures and the growing digital interaction of people; responses articulated through a set of specific measures and plans to minimize risk and maximize the protection of their businesses. Being a member of the Indra Group, one of the leading global technology and consultancy companies with business operations in 140 countries, provides SIA with a profound knowledge of the industries as well as a solid worldwide presence. Further information at www.sia.es .
About RedIRIS
RedIRIS is the Spanish academic and research network that provides advanced communication services to the scientific community and national universities. It is funded by the Ministry of Science and Innovation and is included in the Ministry’s map of Special Scientific and Technological Facilities (ICTS). It is managed by the Public Corporate Entity Red.es, which reports to the Ministry of Economic Affairs and Digital Transformation. RedIRIS has over 500 affiliated institutions, mainly universities and public research centres, which join this community by signing an affiliation agreement. www.rediris.es
Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210921005058/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom